Table 1.
Patient Demographics & Comorbidities (N = 307)
| Characteristic | % | Characteristic | % |
|---|---|---|---|
| Age, mean (SD) | 8 | Sleep Apnea | 7 |
| Race | CAD | 13 | |
| White | 86 | Stroke | 1 |
| Black | 10 | Primary Treatment | |
| Asian | 2 | RP | 10 |
| Other | 1 | RT | 31 |
| Unknown/ not reported | 2 | RP + RT | 55 |
| Ethnicity | Primary ADT | 5 | |
| Hispanic | 3 | ADT Agents | |
| Non Hispanic | 51 | GnRH agonist | 94 |
| Unknown/ not reported | 46 | GnRH antagonist | 17 |
| Smoking Status | Other | 10 | |
| Current | 10 | ADT Exposure | |
| Former | 44 | <6 months | 47 |
| Never | 34 | 6 – 12 months | 19 |
| Unknown/ not reported | 12 | 12 – 24 months | 15 |
| HTN | 54 | 24+ months | 20 |
| DM | 12 | ||
| HLD | 50 |
HTN = Hypertension; HLD = Hyperlipidemia; DM= Diabetes Mellitus; GnRH= Gonadotropin-Releasing Hormone; ADT= Androgen Deprivation Therapy; CAD = Coronary Artery Disease